Related Experiment Video
Updated: Jun 22, 2026
07:51
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
Update in idiopathic pulmonary fibrosis
Stephen K Frankel1, Marvin I Schwarz
1Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Denver, Colorado, USA. frankels@NJHealth.org
Current Opinion in Pulmonary Medicine
|June 25, 2009
Summary
Recent advances improve the diagnosis and management of idiopathic pulmonary fibrosis (IPF). While challenging, ongoing research shows progress in understanding IPF natural history and developing new treatments.
Area of Science:
- Pulmonology
- Medical Research
Background:
- Idiopathic pulmonary fibrosis (IPF) presents significant diagnostic and therapeutic challenges.
- Understanding the natural history of IPF is crucial for patient management.
Purpose of the Study:
- To review recent advancements in the natural history, diagnosis, and management of IPF.
- To contextualize current insights and ongoing research in IPF.
Main Methods:
- Literature review of recent studies on IPF.
- Analysis of diagnostic criteria and technological improvements.
- Evaluation of recent clinical trials for IPF treatments.
Main Results:
- Diagnostic accuracy for IPF is improving with new technologies and practice standards.
- Concomitant pulmonary hypertension and acute exacerbations are key factors in IPF progression.
- While many novel IPF treatments failed, some trials show significant therapeutic benefits, indicating progress.
Conclusions:
- IPF remains a complex condition for clinicians.
- Knowledge regarding IPF natural history, diagnosis, and treatment is continuously evolving.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:30Pulmonary Hypertension: Classification and Pathogenesis
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
01:24Chronic Obstructive Pulmonary Disease
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:23Chronic Obstructive Pulmonary Disease I: Introduction
Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
01:24Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...